文献速递血管炎

进一步拓展巨细胞动脉炎的临床谱:非经典器官受累与罕见并发症

Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications.
PubMed 文献 · Semin Arthritis Rheum · 2025-08-12

该回顾性研究分析了2005至2024年间确诊的174例巨细胞动脉炎(GCA)患者,评估非经典表现和少见并发症的频率与谱系。结果显示29.9%的患者出现至少一种非经典器官表现,包括心脏、呼吸、神经、胃肠及唾液腺18F-FDG摄取增高等,PET-CT还发现肾动脉炎和脾系无症状受累等罕见大中血管受累。作者认为这些非经典并发症可在初诊时出现,早期识别和治疗是降低发病率与死亡率的关键。

要点

  • 174例GCA患者中29.9%出现至少一种非经典器官表现。
  • PET-CT诊断时发现肾动脉炎2.9%、无症状脾系受累4.6%。
  • 非经典表现可为GCA初始表现,评估和随访时应考虑。

核心结论

  • 除经典颅动脉和颅外动脉模式外,相当比例GCA患者可出现非典型或非经典并发症,有时作为初始表现。
  • 这些表现应在评估和随访中加以考虑,早期识别和治疗是降低发病率与死亡率的关键。

研究设计与样本

  • 回顾性研究,分析2005年至2024年间连续纳入的174例确诊GCA患者。

主要发现

  • 174例GCA患者中52例(29.9%)出现一种或多种非经典器官表现。
  • 心脏受累占7.5%(缺血性心脏病或心包炎),原发性呼吸系统疾病占13.8%(胸膜疾病、咽痛、持续干咳、间质性肺病和肺部炎性结节)。
  • 卒中以外的神经系统并发症占2.3%(周围神经病、癫痫和脊髓梗死),胃肠道受累占1.1%,唾液腺18F-FDG摄取增高占5.7%。
  • 诊断时PET-CT显示罕见中大型血管受累:肾动脉血管炎占2.9%(无肾功能不全或尿液异常),无症状脾系受累(腹腔干或肠系膜上动脉)占4.6%。
  • 其他少见表现:继发性淀粉样变占1.1%,头皮、舌或唇坏死或受累占2.3%,颈动脉痛占5.2%,明显听前庭受累(包括感音神经性听力损失或前庭功能障碍)占3.4%,PMR以外的肌肉骨骼症状占10.3%(周围关节炎和缓解性远端肢体肿胀伴凹陷性水肿),骨髓18F-FDG弥漫性摄取增高占15.5%,多自身免疫占10.3%。

临床怎么用

  • 作者认为,非经典并发症有时可作为GCA的初始表现,评估和随访中应考虑这些表现。
  • 作者指出,早期识别和治疗是降低GCA患者发病率与死亡率的关键。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The increasing use of imaging techniques, particularly 18F-FDG PET-CT, together with autopsy findings, has significantly expanded our understanding of the clinical spectrum of giant cell arteritis (GCA). This study aimed to assess the frequency and spectrum of non-classical manifestations and other infrequent complications of the disease METHODS: This retrospective study analyzed a consecutive cohort of 174 patients with proven GCA diagnosed between 2005 and 2024. RESULTS: Among 174 GCA patients, 52 (29.9%) presented with one or more non-classical organ manifestations, including cardiac involvement in 7.5% (ischaemic heart disease or pericarditis), primary respiratory disease in 13.8% (pleural disease, sore throat, persistent dry cough, interstitial lung disease, and pulmonary inflammatory nodules), neurological complications beyond strokes in 2.3% (peripheral neuropathy, epilepsy, and spinal cord infarction), gastrointestinal involvement in 1.1%, and increased 18F-FDG uptake in salivary glands in 5.7%. Beyond these manifestations, PET-CT at diagnosis revealed uncommon medium-to-large vessel involvement, including renal artery vasculitis in 2.9% (without renal insufficiency or urinary abnormalities) and asymptomatic splanchnic involvement (coeliac trunk or superior mesenteric artery) in 4.6%. Other infrequent manifestations included secondary amyloidosis in 1.1%, necrosis or involvement of the scalp, tongue, or lips in 2.3%, carotidynia in 5.2%, overt audiovestibular involvement (including sensorineural hearing loss or vestibular dysfunction) in 3.4%, musculoskeletal symptoms beyond PMR in 10.3% (peripheral arthritis and remitting distal extremity swelling with pitting oedema), diffuse increase in bone marrow 18F-FDG uptake in 15.5%, and polyautoimmunity in 10.3%. CONCLUSION: Beyond the classical cranial and extracranial patterns, which often coexist, a significant proportion of GCA patients may present with atypical or non-classical complications, sometimes as the initial manifestation. These should be considered during evaluation and follow-up, as early recognition and treatment are key to reducing morbidity and mortality.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Narváez J, Vidal-Montal P, Maymó-Paituvi P, et al. Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications. Semin Arthritis Rheum. 2025. PMID: 40818184. doi:10.1016/j.semarthrit.2025.152817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。